Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Russell A. Judge is active.

Publication


Featured researches published by Russell A. Judge.


Biophysical Journal | 1999

THE EFFECT OF TEMPERATURE AND SOLUTION PH ON THE NUCLEATION OF TETRAGONAL LYSOZYME CRYSTALS

Russell A. Judge; Randolph S. Jacobs; Tyralynn Frazier; Edward H. Snell; Marc L. Pusey

Part of the challenge of macromolecular crystal growth for structure determination is obtaining crystals with a volume suitable for x-ray analysis. In this respect an understanding of the effect of solution conditions on macromolecule nucleation rates is advantageous. This study investigated the effects of supersaturation, temperature, and pH on the nucleation rate of tetragonal lysozyme crystals. Batch crystallization plates were prepared at given solution concentrations and incubated at set temperatures over 1 week. The number of crystals per well with their size and axial ratios were recorded and correlated with solution conditions. Crystal numbers were found to increase with increasing supersaturation and temperature. The most significant variable, however, was pH; crystal numbers changed by two orders of magnitude over the pH range 4.0-5.2. Crystal size also varied with solution conditions, with the largest crystals obtained at pH 5.2. Having optimized the crystallization conditions, we prepared a batch of crystals under the same initial conditions, and 50 of these crystals were analyzed by x-ray diffraction techniques. The results indicate that even under the same crystallization conditions, a marked variation in crystal properties exists.


Journal of Medicinal Chemistry | 2015

Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.

Milan Bruncko; Le Wang; George S. Sheppard; Darren C. Phillips; Stephen K. Tahir; John Xue; Scott A. Erickson; Steve D. Fidanze; Elizabeth E. Fry; Lisa A. Hasvold; Gary J. Jenkins; Sha Jin; Russell A. Judge; Peter Kovar; David J. Madar; Paul Nimmer; Chang Park; Andrew M. Petros; Saul H. Rosenberg; Morey L. Smith; Xiaohong Song; Chaohong Sun; Zhi-Fu Tao; Xilu Wang; Yu Xiao; Haichao Zhang; Chris Tse; Joel D. Leverson; Steve W. Elmore; Andrew J. Souers

Myeloid cell leukemia 1 (MCL-1) is a BCL-2 family protein that has been implicated in the progression and survival of multiple tumor types. Herein we report a series of MCL-1 inhibitors that emanated from a high throughput screening (HTS) hit and progressed via iterative cycles of structure-guided design. Advanced compounds from this series exhibited subnanomolar affinity for MCL-1 and excellent selectivity over other BCL-2 family proteins as well as multiple kinases and GPCRs. In a MCL-1 dependent human tumor cell line, administration of compound 30b rapidly induced caspase activation with associated loss in cell viability. The small molecules described herein thus comprise effective tools for studying MCL-1 biology.


Biotechnology and Bioengineering | 1998

The effect of protein impurities on lysozyme crystal growth

Russell A. Judge; Elizabeth L. Forsythe; Marc L. Pusey

While bulk crystallization from impure solutions is used industrially as a purification step for a wide variety of materials, it is a technique that has rarely been used for proteins. Proteins have a reputation for being difficult to crystallize and high purity of the initial crystallization solution is considered paramount for success in the crystallization. Although little is written on the purifying capability of protein crystallization or of the effect of impurities on the various aspects of the crystallization process, recent published reports show that crystallization shows promise and feasibility as a purification technique for proteins. To further examine the issue of purity in macromolecule crystallization, this study investigates the effect of the protein impurities, avidin, ovalbumin, and conalbumin at concentrations up to 50%, on the solubility, crystal face growth rates, and crystal purity of the protein lysozyme. Solubility was measured in batch experiments while a computer controlled video microscope system was used to measure the ¿110¿ and ¿101¿ lysozyme crystal face growth rates. While little effect was observed on solubility and high crystal purity was obtained (>99.99%), the effect of the impurities on the face growth rates varied from no effect to a significant face specific effect leading to growth cessation, a phenomenon that is frequently observed in protein crystal growth. The results shed interesting light on the effect of protein impurities on protein crystal growth and strengthen the feasibility of using crystallization as a unit operation for protein purification.


Acta Crystallographica Section D-biological Crystallography | 2005

An ultraviolet fluorescence-based method for identifying and distinguishing protein crystals

Russell A. Judge; Kerry M. Swift; Carlos Gonzalez

Intrinsic ultraviolet fluorescence has been investigated as a rapid non-invasive method for identifying and distinguishing protein crystals. An epi-fluorescence microscope, which provides for excitation and viewing of fluorescence from above the sample, and a straight-through geometry, which provides excitation from above and views fluorescence from underneath the sample, were tested with protein and non-protein crystal samples. In both systems the protein crystals were observed to fluoresce brightly, providing a high contrast against background solution fluorescence, thus enabling protein crystals to be identified and distinguished from non-protein crystals.


Acta Crystallographica Section D-biological Crystallography | 2005

Extracting trends from two decades of microgravity macromolecular crystallization history.

Russell A. Judge; Edward H. Snell; Mark J. van der Woerd

Since the 1980s hundreds of macromolecular crystal growth experiments have been performed in the reduced acceleration environment of an orbiting spacecraft. Significant enhancements in structural knowledge have resulted from X-ray diffraction of the crystals grown. Similarly, many samples have shown no improvement or degradation in comparison to those grown on the ground. A complex series of interrelated factors affect these experiments and by building a comprehensive archive of the results it was aimed to identify factors that result in success and those that result in failure. Specifically, it was found that dedicated microgravity missions increase the chance of success when compared with those where crystallization took place as a parasitic aspect of the mission. It was also found that the chance of success could not be predicted based on any discernible property of the macromolecule available to us.


Acta Crystallographica Section D-biological Crystallography | 2014

Neutron structure of the cyclic glucose-bound xylose isomerase E186Q mutant.

Parthapratim Munshi; Edward H. Snell; Mark J. van der Woerd; Russell A. Judge; Dean A. A. Myles; Zhong Ren; Flora Meilleur

Ketol-isomerases catalyze the reversible isomerization between aldoses and ketoses. D-Xylose isomerase carries out the first reaction in the catabolism of D-xylose, but is also able to convert D-glucose to D-fructose. The first step of the reaction is an enzyme-catalyzed ring opening of the cyclic substrate. The active-site amino-acid acid/base pair involved in ring opening has long been investigated and several models have been proposed. Here, the structure of the xylose isomerase E186Q mutant with cyclic glucose bound at the active site, refined against joint X-ray and neutron diffraction data, is reported. Detailed analysis of the hydrogen-bond networks at the active site of the enzyme suggests that His54, which is doubly protonated, is poised to protonate the glucose O5 position, while Lys289, which is neutral, promotes deprotonation of the glucose O1H hydroxyl group via an activated water molecule. The structure also reveals an extended hydrogen-bonding network that connects the conserved residues Lys289 and Lys183 through three structurally conserved water molecules and residue 186, which is a glutamic acid to glutamine mutation.


European Biophysics Journal | 2006

Optimizing crystal volume for neutron diffraction: D-xylose isomerase

Edward H. Snell; Mark J. van der Woerd; Michael Damon; Russell A. Judge; Dean A. A. Myles; Flora Meilleur

Neutron diffraction is uniquely sensitive to hydrogen positions and protonation state. In that context structural information from neutron data is complementary to that provided through X-ray diffraction. However, there are practical obstacles to overcome in fully exploiting the potential of neutron diffraction, i.e. low flux and weak scattering. Several approaches are available to overcome these obstacles and we have investigated the simplest: increasing the diffracting volume of the crystals. Volume is a quantifiable metric that is well suited for experimental design and optimization techniques. By using response surface methods we have optimized the xylose isomerase crystal volume, enabling neutron diffraction while we determined the crystallization parameters with a minimum of experiments. Our results suggest a systematic means of enabling neutron diffraction studies for a larger number of samples that require information on hydrogen position and/or protonation state.


Biochemistry | 2014

Water channel in the binding site of a high affinity anti-methotrexate antibody.

Susan Gayda; Kenton L. Longenecker; Sharmila Manoj; Russell A. Judge; Sylvia C. Saldana; Qiaoqiao Ruan; Kerry M. Swift; Sergey Y. Tetin

In the present study, we report the structure of the free and drug-bound Fab fragment of a high affinity anti-methotrexate antibody and perform a thermodynamic analysis of the binding process. The anti-methotrexate Fab fragment features a remarkably rigid tunnel-like binding site that extends into a water channel serving as a specialized route to move solvent out and into the site upon ligand binding and dissociation. This new finding in antibody structure-function relationships directly relates to the fast association (1 × 10⁷ M⁻¹ s⁻¹) and slow dissociation (4 × 10⁻⁵ s⁻¹) rates determined for mAb ADD056, resulting in a very strong binding with a K(D) ~ 3.6 pM at 20 °C. As follows from the X-ray data analysis, the methotrexate-antibody complex is stabilized by an extended network of hydrogen bonds and stacking interactions. The analysis also shows structural involvement of the CDR H3 in formation of the water channel revealing another important role of this hypervariable region. This suggests a new direction in natural affinity maturation and opens a new possibility in antibody engineering. Methotrexate is a widely used therapeutic agent for many malignant diseases and inflammatory disorders. Unfortunately, it may also interfere with central aspects of metabolism and thereby cause inevitable side effects. Therefore, methotrexate therapy requires careful monitoring of drug blood levels, which is traditionally done by immunoassays. An understanding of the structure-function properties of antibodies selected for drug monitoring substantiates the performance and robustness of such tests.


Bioorganic & Medicinal Chemistry Letters | 2018

Targeting lysine specific demethylase 4A (KDM4A) tandem TUDOR domain – A fragment based approach

Anup K. Upadhyay; Russell A. Judge; Leiming Li; Ron Pithawalla; Justin Simanis; Pierre M. Bodelle; Violeta L. Marin; Rodger F. Henry; Andrew M. Petros; Chaohong Sun

The tandem TUDOR domains present in the non-catalytic C-terminal half of the KDM4A, 4B and 4C enzymes play important roles in regulating their chromatin localizations and substrate specificities. They achieve this regulatory role by binding to different tri-methylated lysine residues on histone H3 (H3-K4me3, H3-K23me3) and histone H4 (H4-K20me3) depending upon the specific chromatin environment. In this work, we have used a 2D-NMR based fragment screening approach to identify a novel fragment (1a), which binds to the KDM4A-TUDOR domain and shows modest competition with H3-K4me3 binding in biochemical as well as in vitro cell based assays. A co-crystal structure of KDM4A TUDOR domain in complex with 1a shows that the fragment binds stereo-specifically to the methyl lysine binding pocket forming a network of strong hydrogen bonds and hydrophobic interactions. We anticipate that the fragment 1a can be further developed into a novel allosteric inhibitor of the KDM4 family of enzymes through targeting their C-terminal tandem TUDOR domain.


Biopolymers | 2016

Three‐dimensional structure, binding, and spectroscopic characteristics of the monoclonal antibody 43.1 directed to the carboxyphenyl moiety of fluorescein

Susan Gayda; Kenton L. Longenecker; Russell A. Judge; Kerry M. Swift; Sharmila Manoj; D. Scott Linthicum; Sergey Y. Tetin

Unlike other known anti‐fluorescein antibodies, the monoclonal antibody 43.1 is directed toward the fluoresceins carboxyl phenyl moiety. It demonstrates a very high affinity (KD ∼ 70 pM) and a fast association rate (kon ∼ 2 × 107 M−1 s−1). The three‐dimensional structure of the Fab 43.1—fluorescein complex was resolved at 2.4 Å resolution. The antibody binding site is exclusively assembled by the CDR loops. It is comprised of a 14 Å groove‐shaped entrance leading to a 9 Å by 7 Å binding pocket. The highly polar binding pocket complementary encloses the fluoresceins carboxyphenyl moiety and tightly fixes it by multiple hydrogen bonds. The fluoresceins xanthene ring is embedded in the more hydrophobic groove and stacked between the side chains of Tyr37L and of Arg99H providing conditions for an excited state electron transfer process. In comparison to fluorescein, the absorption spectrum of the complex in the visible region is shifted to the “red” by 23 nm. The complex demonstrates a very weak fluorescence (Φc = 0.0018) with two short lifetime components: 0.03 ns (47%) and 0.8 ns (24%), which reflects a 99.8% fluorescein emission quenching effect upon complex formation. The antibody 43.1 binds fluorescein with remarkable affinity, fast association rate, and strongly quenches its emission. Therefore, it may present a practical interest in applications such as molecular sensors and switches.

Collaboration


Dive into the Russell A. Judge's collaboration.

Top Co-Authors

Avatar

Edward H. Snell

Hauptman-Woodward Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Marc L. Pusey

Marshall Space Flight Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dean A. A. Myles

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Michael W. Burke

University of Alabama in Huntsville

View shared research outputs
Top Co-Authors

Avatar

Flora Meilleur

North Carolina State University

View shared research outputs
Top Co-Authors

Avatar

Gloria E. O. Borgstahl

Eppley Institute for Research in Cancer and Allied Diseases

View shared research outputs
Top Co-Authors

Avatar

Henry D. Bellamy

Louisiana State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge